肿瘤休眠机制

doi:10.3760/cma.j.issn.1673422X.2015.09.009

摘要/Abstract

摘要： 肿瘤休眠是肿瘤发生发展的一个阶段。近年来随着对循环肿瘤细胞、播散肿瘤细胞和肿瘤干细胞的深入研究，发现它们与肿瘤休眠密切相关。此外，肿瘤微环境也是导致肿瘤休眠的另一重要因素。

刘静文, 刘红利. 肿瘤休眠机制[J]. 国际肿瘤学杂志, 2015, 42(8): 675-.

LIU Jing-Wen, LIU Hong-Li. Mechanism of tumor dormancy[J]. Journal of International Oncology, 2015, 42(8): 675-.

［1］ Wendt MK, Balanis N, Carlin CR, et al. STAT3 and epithelialmesenchymal transitions in carcinomas［J］. JAKSTAT, 2014, 3(1): e28975. ［2］ Zhou N, Wu X, Yang B, et al. Stem cell characteristics of dormant cells and cisplatininduced effects on the stemness of epithelial ovarian cancer cells［J］. Mol Med Rep, 2014, 10(5): 24952504. ［3］ Niess H, Camaj P, Renner A, et al. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis［J］. Target Oncol, 2014, 10(2): 215227. ［4］ Di Stefano AB, Iovino F, Lombardo Y, et al. Survivin is regulated by interleukin4 in colon cancer stem cells［J］. J Cell Physiol, 2010, 225(2): 555561. ［5］ Volonté A, Di Tomaso T, Spinelli M, et al. Cancerinitiating cells from colorectal cancer patients escape from T cellmediated immunosurveillance in vitro through membranebound IL4［J］. J Immunol, 2014, 192(1): 523532. ［6］ Chao YL, Shepard CR, Wells A. Breast carcinoma cells reexpress Ecadherin during mesenchymal to epithelial reverting transition［J］. Mol Cancer, 2010, 9: 179. ［7］ Chao Y, Wu Q, Shepard C, et al. Hepatocyte induced reexpression of Ecadherin in breast and prostate cancer cells increases chemoresistance［J］. Clin Exp Metastasis, 2012, 29(1): 3950. ［8］ Nishikawa S, Ishii H, Haraguchi N, et al. Genotoxic therapy stimulates errorprone DNA repair in dormant hepatocellular cancer stem cells［J］. Exp Ther Med, 2012, 3(6): 959962. ［9］ Sosa MS, Bragado P, Debnath J, et al. Regulation of tumor cell dormancy by tissue microenvironments and autophagy［J］. Adv Exp Med Biol, 2013, 734: 7389. ［10］ Rogers MS, Novak K, Zurakowski D, et al. Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors［J］. Mol Cancer Res, 2014, 12(5): 754764. ［11］ Pajonk F, Vlashi E, McBride WH. Radiation resistance of cancer stem cells: the 4 R′s of radiobiology revisited［J］. Stem Cells, 2010, 28(4): 639648. ［12］ Hu Y, Hu MM, Shi GL, et al. Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable nonsmall cell lung cancer［J］. Eur J Surg Oncol, 2014, 40(9): 11361142. ［13］ Lyu T, Jia N, Wang J, et al. Expression and epigenetic regulation of angiogenesisrelated factors during dormancy and recurrent growth of ovarian carcinoma［J］. Epigenetics, 2013, 8(12): 13301346. ［14］ Zhang G, Miyake M, Lawton A, et al. Matrix metalloproteinase10 promotes tumor progression through regulation of angiogenenic and apoptotic pathways in cervical tumors［J］. BMC Cancer, 2014, 14: 310. ［15］ Straume O, Shimamura T, Lampa MJ, et al. Suppression of heat shock protein 27 induces longterm dormancy in human breast cancer［J］. Proc Natl Acad Sci USA, 2012, 109(22): 86998704. ［16］ Guichet PO, Guelfi S, Teigell M, et al. Notch1 stimulation induces a vascularization switch with pericytelike cell differentiation of glioblastoma stem cells［J］. Stem Cells, 2015, 33(1): 2134. ［17］ Mittal D, Gubin MM, Schreiber RD, et al. New insights into cancer immunoediting and its three component phaseselimination, equilibrium and escape［J］. Curr Opin Immunol, 2014, 27: 1625. ［18］ Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2positive advanced gastric or gastrooesophageal junction cancer (ToGA): a phase 3, openlabel, randomised controlled tria［J］. Lancet, 2010, 376(9742): 687697. ［19］ Perez EA, Romond EH, Suman VJ, et al. Fouryear followup of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B31［J］. J Clin Oncol, 2011, 29(25): 33663373. ［20］ Primrose J, Falk S, FinchJones M, et al. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomized controlled trial［J］. Lancet Oncol, 2014, 15(6): 601611. ［21］ Wefers C, Lamberrt LJ, Torensma R, et al. Cellular immunotherapy in ovarian cancer: targeting the stem of recurrence［J］. Gynecol Oncol, 2015, 137(2): 335342. ［22］ Vivier E, Ugolini S, Blaise D, et al. Targeting natural killer cells and natural killer T cells in cancer［J］. Nat Rev Immunol, 2012, 12(4): 239252. ［23］ Sun Y, Peng S, Qiu J, et al. Intravaginal HPV DNA vaccination with electroporation induces local CD8+ Tcell immune responses and antitumor effects against cervicovaginal tumors［J］. Gene Ther, 2015, In press. ［24］ Vasaturo A, Di Blasio S, Peeters DG, et al. Clinical implications of coinhibitory molecule expression in the tumor microenvironment for DC vaccination: a game of stop and go［J］. Front Immunol, 2013, 4: 417. ［25］ Bragado P, Sosa MS, Keely P, et al. Microenvironments dictating tumor cell dormancy［J］. Recent Results Cancer Res, 2012, 195: 2539. ［26］ Yumoto K, Eber MR, Berry JE, et al. Molecular pathways: niches in metastatic dormancy［J］. Clin Cancer Res, 2014, 20(13): 33843389. ［27］ Pulukuri SM, Gorantla B, Dasari VR, et al. Epigenetic upregulation of urokinase plasminogen activator promotes the ropism of mesenchymal stem cells for tumor cells［J］. Mol Cancer Res, 2010, 8(8): 10741083. ［28］ Ferraris GM, Schulte C, Buttiglione V, et al. The interaction between uPAR and vitronectin triggers ligandindependent andhesion signaling by integrins［J］. EMBO J, 2014, 33(21): 24582472. ［29］ André N, Carré M, Pasquier E. Metronomics: towards personalized chemotherapy?［J］. Nat Rev Clin Oncol, 2014, 11(7): 413431.

肿瘤休眠机制

Mechanism of tumor dormancy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价